Skip to main content
Top
Published in: Diabetologia 4/2010

01-04-2010 | Article

Dimorphic histopathology of long-standing childhood-onset diabetes

Authors: R. Gianani, M. Campbell-Thompson, S. A. Sarkar, C. Wasserfall, A. Pugliese, J. M. Solis, S. C. Kent, B. J. Hering, E. West, A. Steck, S. Bonner-Weir, M. A. Atkinson, K. Coppieters, M. von Herrath, G. S. Eisenbarth

Published in: Diabetologia | Issue 4/2010

Login to get access

Abstract

Aims/hypothesis

Childhood diabetes is thought to usually result from autoimmune beta cell destruction (type 1A) with eventual total loss of beta cells. Analysis of C-peptide in children characterised at diabetes onset for autoantibodies shows heterogeneous preservation of insulin secretion in long-standing diabetes. The aim of this study was to characterise the pancreases of childhood-onset diabetes in order to define the pathological basis of this heterogeneity.

Methods

We evaluated 20 cadaveric organ donor pancreases of childhood-onset long-term patients for disease heterogeneity and obtained corresponding C-peptide measurements.

Results

Pancreases from the majority of cadaveric donors contained only insulin-deficient islets (14 of 20). The remaining six patients (30%) had numerous insulin-positive cells within at least some islets, with two different histological patterns. Pattern A (which we would associate with type 1A diabetes) had lobular retention of areas with ‘abnormal’ beta cells producing the apoptosis inhibitor survivin and HLA class I. In pattern B, 100% of all islets contained normal-appearing but quantitatively reduced beta cells without survivin or HLA class I.

Conclusions/interpretation

Our data demonstrate that C-peptide secretion in long-standing diabetic patients can be explained by two different patterns of beta cell survival, possibly reflecting different subsets of type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Spencer J, Peakman M (2009) Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell. Clin Exp Immunol 155:125–127CrossRefPubMed Spencer J, Peakman M (2009) Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell. Clin Exp Immunol 155:125–127CrossRefPubMed
2.
go back to reference Dotta F, Eisenbarth GS (1989) Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. Clin Immunol Immunopathol 50:85–95CrossRef Dotta F, Eisenbarth GS (1989) Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. Clin Immunol Immunopathol 50:85–95CrossRef
3.
4.
go back to reference Vaxillaire M, Bonnefond A, Froquel P (2009) Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. Pediatr Endocrinol Rev 6:405–417PubMed Vaxillaire M, Bonnefond A, Froquel P (2009) Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. Pediatr Endocrinol Rev 6:405–417PubMed
5.
go back to reference Maldonado M, Hampe CS, Gaur LK et al (2003) Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classsification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090–5098CrossRefPubMed Maldonado M, Hampe CS, Gaur LK et al (2003) Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classsification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab 88:5090–5098CrossRefPubMed
6.
go back to reference Njolstad PR, Sovk O, Cuesta-Munoz A et al (2008) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588–1592CrossRef Njolstad PR, Sovk O, Cuesta-Munoz A et al (2008) Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 344:1588–1592CrossRef
7.
go back to reference Wang J, Miao D, Babu S et al (2007) Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 92:88–92CrossRefPubMed Wang J, Miao D, Babu S et al (2007) Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 92:88–92CrossRefPubMed
8.
go back to reference Steck KA, Yu L, Armstrong T et al (2009) C-peptide levels correlate with age of onset, duration of diabetes and autoantibody status. Diabetes 58(Suppl 1):A459 (Abstract) Steck KA, Yu L, Armstrong T et al (2009) C-peptide levels correlate with age of onset, duration of diabetes and autoantibody status. Diabetes 58(Suppl 1):A459 (Abstract)
9.
go back to reference Foulis AK, Liddle CN, Farquharson JA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274CrossRefPubMed Foulis AK, Liddle CN, Farquharson JA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274CrossRefPubMed
10.
go back to reference Lohr M, Kloppel G (2004) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762 Lohr M, Kloppel G (2004) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762
11.
go back to reference Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed
12.
go back to reference Liggins C, Orlicky D, Bloomquist L, Gianani R (2008) Developmentally regulated expression of survivin in human pancreatic islets. Pediatr Dev Pathol 6:392–397CrossRef Liggins C, Orlicky D, Bloomquist L, Gianani R (2008) Developmentally regulated expression of survivin in human pancreatic islets. Pediatr Dev Pathol 6:392–397CrossRef
13.
go back to reference Hasel C, Bhanot UK, Maier R, Strater J, Moller P (2005) Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NF kappa B and IAPs. Lab Invest 85:1263–1275CrossRefPubMed Hasel C, Bhanot UK, Maier R, Strater J, Moller P (2005) Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NF kappa B and IAPs. Lab Invest 85:1263–1275CrossRefPubMed
14.
go back to reference Jiang Y, Nishimura W, Devor-Henneman D et al (2008) Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 57:2718–2727CrossRefPubMed Jiang Y, Nishimura W, Devor-Henneman D et al (2008) Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 57:2718–2727CrossRefPubMed
15.
go back to reference Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabets. PNAS 104:17040–17045CrossRefPubMed Wenzlau JM, Juhl K, Yu L et al (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabets. PNAS 104:17040–17045CrossRefPubMed
16.
go back to reference Chen J, Munter P, Hamm LL et al (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 4:469–477CrossRef Chen J, Munter P, Hamm LL et al (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 4:469–477CrossRef
17.
18.
go back to reference Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308CrossRefPubMed Yoon KH, Ko SH, Cho JH et al (2003) Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88:2300–2308CrossRefPubMed
Metadata
Title
Dimorphic histopathology of long-standing childhood-onset diabetes
Authors
R. Gianani
M. Campbell-Thompson
S. A. Sarkar
C. Wasserfall
A. Pugliese
J. M. Solis
S. C. Kent
B. J. Hering
E. West
A. Steck
S. Bonner-Weir
M. A. Atkinson
K. Coppieters
M. von Herrath
G. S. Eisenbarth
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1642-y

Other articles of this Issue 4/2010

Diabetologia 4/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.